<DOC>
	<DOCNO>NCT00510211</DOCNO>
	<brief_summary>The primary objective study assess proportion schizophrenic patient proportion bipolar patient discontinue olanzapine within 12 month treatment outpatient , ambulatory community setting</brief_summary>
	<brief_title>An Observational Study Olanzapine Coated Orodispersible Tablets Effectiveness Schizophrenic Bipolar Outpatients .</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>patient suffer schizophrenic schizoaffective disorder base disease diagnostic criterion DSM IV prescribe olanzapine 45 preceding day . patient suffer bipolar disorder base disease diagnostic criterion DSM IV prescribe olanzapine 45 precede day one following : moderate severe manic episode relapse prevention patient bipolar disorder current treatment investigational drug procedure entry whole study hypersensitivity olanzapine patient know narrow angle glaucoma risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>